Abstract
Aims/hypothesis CVD remains a major cause of mortality in people with long-duration type 1 diabetes, even among those without diabetic kidney disease (DKD). We assessed biomarkers that may be associated with CVD risks among the Joslin ‘Medalists’, namely those with type 1 diabetes of ≥50 years. Methods In this cross-sectional study, participants were evaluated for self-reported CVD (n=1038), with subsets undergoing coronary artery calcium (CAC; n=142) and cardiac magnetic resonance (CMR; n=111) imaging. Using multivariable regression analysis, multiple circulating factors such as inflammatory biomarkers and osteopontin (n=300) were analysed for associations with CVD, CAC and CMR, adjusting for DKD and other cardiometabolic and glycaemic risk factors, including HbA1c, continuous glucose monitor (n=102) metrics and advanced glycation end-products (n=200). Results Only 32% of participants had DKD (eGFR 2), but 40% had CVD. Despite having excellent cardiometabolic management (mean blood pressure of 132/64 mmHg; LDL and HDL-cholesterol of 2.10 mmol/l and 1.69 mmol/l, respectively, and a median HbA1c of 54.1 mmol/mol [7.1%]), participants exhibited a high CAC burden (median score 937), which did not differ between those with and without DKD (1136 vs 878, respectively). Among the glycaemic markers, HbA1c, but not hypoglycaemia or glycaemic variability, remained associated with CVD (OR 1.40, pp<0.01) in the non-DKD group compared with the DKD group. Conclusions/interpretation Ageing people with long-duration type 1 diabetes and without DKD, but with excellent cardiometabolic management, still possess a high burden of coronary atherosclerosis. Improving hyperglycaemia and mitigating inflammation, especially osteopontin, are potentially important for the management of CVD in long-duration type 1 diabetes. Graphical Abstract
Funding Information
  • American Diabetes Association (ADA 9-18-CVD1-005)
  • Thomas J. Beatson Foundation (Beatson 50-Year Medalist Fund, Beatson Pledge Fund)
  • Iacocca Family Foundation
  • National Heart, Lung, and Blood Institute (R01 HL155717, R01 HL161864-01)
  • Dianne Nunnally Hoppes Fund
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK036836)

This publication has 40 references indexed in Scilit: